Latest news
Capricor Therapeutics Lawsuit: CAPR Investors Focus on Alleged FDA Disclosure Issues and Stock Drops - tipranks.comtipranks.com · Fri, 07 Aug 2026 19:27:29 GMTINVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMTFDA PDUFA Watch: Neurology Decisions to Track Through Late September - NeurologyLiveNeurologyLive · Thu, 06 Aug 2026 14:15:45 GMTCAPR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 29, 2026 - Business WireBusiness Wire · Wed, 05 Aug 2026 20:54:00 GMTFDA Neurology Roundup: July 2026 - MedscapeMedscape · Wed, 05 Aug 2026 11:57:35 GMTFDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy NewsMuscular Dystrophy News · Tue, 04 Aug 2026 17:04:06 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - MorningstarMorningstar · Tue, 04 Aug 2026 15:36:00 GMTINVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - Business WireBusiness Wire · Tue, 04 Aug 2026 00:00:00 GMT